Changeflow GovPing Healthcare & Life Sciences EP4438601A1 Tricyclic Derivative Patent, Shangh...
Routine Notice Added Final

EP4438601A1 Tricyclic Derivative Patent, Shanghai Jemincare, Apr 15

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

Shanghai Jemincare Pharmaceutical Co., Ltd. obtained publication EP4438601A1 on April 15, 2026 for a tricyclic derivative and its preparation method and pharmaceutical application. The patent covers compounds classified under multiple C07D subclasses and is designated across all EPO member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR. The application also references A61K pharmaceutical compositions and A61P therapeutic uses, including A61P 11/00 covering respiratory conditions.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 63 changes logged to date.

Notice an inaccuracy or want this record removed? Email corrections@changeflow.com . We respond within 48 hours and honor reasonable requests. See our editorial standards .

What changed

The EPO published patent application EP4438601A1 for a tricyclic derivative and its preparation method and pharmaceutical application by Shanghai Jemincare Pharmaceutical Co., Ltd. The patent is classified under multiple organic chemistry IPC subclasses (C07D 417/14, C07D 471/04, C07D 487/08, C07D 491/044, C07D 519/00) and designates all EPO contracting states. The application also covers pharmaceutical compositions (A61K 31/4353) and therapeutic uses including respiratory conditions (A61P 11/00). This publication establishes a priority date and publicly discloses the technical content of the invention.

Pharmaceutical companies engaged in tricyclic compound research or developing similar therapeutic applications should review this publication for freedom-to-operate considerations, potential licensing opportunities, or competitive landscape assessment in respiratory and related therapeutic indications within EPO-designated territories.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Publication EP4438601A1 Kind: A1 Apr 15, 2026

Applicants

Shanghai Jemincare Pharmaceutical Co., Ltd.

Inventors

DENG, Gang, GUO, Shuchun, FAN, Jun, ZHANG, Zhitao, WU, Nan, SHI, Wenqiang, FANG, Zhihua, FENG, Jianbo, PENG, Jianbiao, GUO, Haibing

IPC Classifications

C07D 417/14 20060101AFI20250320BHEP A61K 31/4353 20060101ALI20250320BHEP A61P 11/00 20060101ALI20250320BHEP C07D 471/04 20060101ALI20250320BHEP C07D 471/10 20060101ALI20250320BHEP C07D 487/08 20060101ALI20250320BHEP C07D 487/10 20060101ALI20250320BHEP C07D 491/044 20060101ALI20250320BHEP C07D 491/147 20060101ALI20250320BHEP C07D 519/00 20060101ALI20250320BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication Chemical compound research Therapeutic development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Chemical Manufacturing Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!